New ICD Codes and IPPS Changes for FY2021 (ICD-10-CM Diagnoses changes) – Part 3
RHIA, CDIP, CCS, CCS‑P, CIRCC
Executive Director Of Education
AHIMA‑Approved ICD‑10‑CM/PCS Trainer and Ambassador
In the previous two parts of this four part series, we discussed the new ICD-10-CM diagnosis code changes and ICD-10-PC procedure code changes. In this session we will review the major IPPS changes for FY2021.
IPPS Changes Financial
On September 2, 2020, CMS published the Final Rule for IPPS (CMS-1735F) It was a month late due to the COVID-19 pandemic. FY2021 IPPS Final Rule
Acute care hospitals that report quality data and that are meaningful users of EHRs will receive approximately a 2.7% increase in Medicare operating rates. Hospitals that do not submit quality data would lose 1/4 (-25%) of the market basket update (of 2.7% as above) and hospitals that are not meaningful users of EHRs will be subject to a 3/4 )_0.75%)reduction of the market basket for FY 2021.
CMS is finalizing an alternative pathway for certain antimicrobial products based on significant concerns with the ongoing public health crisis represented by antimicrobial resistance.
CMS is projecting that with the 2.7% increase and other changes to IPPS policies it will boost total IPPS payments in FY2021 by roughly $3.5 billion.
There were no new changes to the Post-Acute Care Transfer Policy for FY2021.
Hospitals are required to report measures and meet the administrative requirements of the IQR program to avoid having their annual market basket update reduced by one quarter. The IQR also includes requirements to report electronic clinical quality measures (eCQMs) that align with the eCQM reporting requirements in the Promoting Interoperability Program. (Generated by provider’s E.H.R.) See https://www.cms.gov/Regulations-and-Guidance/Legislation/EHRIncentivePrograms/ClinicalQualityMeasures.html
No new measures for IQR in FY2021. CMS did make some changes to the hospital reporting process and reporting periods of eCQM data and streamlining hospital IQR Program validation processes. See this link for details of these changes: https://www.cms.gov/newsroom/fact-sheets/fiscal-year-fy-2021-medicare-hospital-inpatient-prospective-payment-system-ipps-and-long-term-acute
For the Hospital-Acquired Condition (HAC) Reduction Program, no changes to the scoring methodology will be made in FY2021.
For the FY 2021 IPPS/LTCH PPS Final rule, CMS is finalizing to automatically adopt applicable periods (i.e., performance periods for measures used in the Program) beginning with the FY 2023 program year and all subsequent program years and update the definition of applicable period at 42 CFR 412.152 to align with the automatic adoption proposal.
There were several changes involving DRGs. Below are the changes.
Pre-MDC: Allogeneic Bone Marrow Transplant: CMS finalizing to re-designate MS-DRG 014 (Allogeneic Bone Marrow Transplant), MS-DRG 016 (Autologous Bone Marrow Transplant with CC/MCC or T-Cell Immunotherapy), and MS-DRG 017 (Autologous Bone Marrow Transplant without CC/MCC) from surgical MS-DRGs to medical MS-DRGs.
- Bone marrow transplants involve transfusions not surgery and do not need an operating room.
- CMS will re-designate the 8 (302—-) transfusion codes to non-OR procedures.
Pre-MDC: Chimeric Antigen Receptor(CAR) T-cell Therapies and its own DRG: CMS finalized to create a new MS-DRG 018, CAR T cell Immunotherapy for CAR T Cell Therapy (Chimeric Antigen Receptor) cases and remove them from Pre-MDC MS-DRG 016 (Autologous Bone Marrow Transplant with CC/MCC or T-Cell Immunotherapy)
- XW033C3, Introduction of engineered autologous chimeric antigen receptor t-cell immunotherapy into peripheral vein, percutaneous approach, new technology group 3
- XW043C3, Introduction of engineered autologous chimeric antigen receptor t-cell immunotherapy into central vein, percutaneous approach, new technology group 3
- Examples are YESCARTA® and KYMRIAH®.
Changed the name of Pre-MDC MS-DRG 016 (Autologous Bone Marrow Transplant with CC/MCC or T-Cell Immunotherapy) by removing the “or T-Cell Immunotherapy.
MDC 1: Carotid Artery Stent: Six codes below were left out last year of MS-DRGS 034, 035, and 036 (Carotid Artery Stent Procedures with MCC, with CC, and without CC/MCC, respectively). So this year they were added into DRGS 034, 035, 036. Eight codes grouping to MS-DRGS 981, 982, 983 moved to DRGS 034, 035, 036. For FY 2021, CMS is also adding the 36 ICD-10-PCS that are currently assigned in MDC 05 in MS-DRGs 252, 253, and 254 to MS-DRGs 034, 035, and 036 in MDC 01. (Dilation of internal, external carotids with various # of stents)
MDC 3: TMJ Replacements: For TMJ replacements, CMS is creating two new base MS-DRGs, 140 and 143, with a three-way severity level split for new MS-DRGs 140, 141, and 142 (Major Head and Neck Procedures with MCC, with CC, and without CC/MCC, respectively) and new MS-DRGs 143, 144, and 145 (Other Ear, Nose, Mouth And Throat O.R. Procedures with MCC, with CC, and without CC/MCC, respectively) See procedure codes listed in Table 6P.2c for the codes. See table 6P.2a and table 6P.2b for the list of procedure codes we are finalizing for reassignment from MS-DRGs 129, 130, 131, 132, 133, and 134 to each of the new MS-DRGs.
MDC 5: Left Atrial Appendage Closure (LAAC) (i.e. WATCHMAN™: CMS is reassigning ICD-10-PCS codes 02L70CK, 02L70DK, and 02L70ZK from MS-DRGs 250 and 251 (Percutaneous Cardiovascular Procedures without Coronary Artery Stent with and without MCC, respectively) to MS-DRGs 273 and 274 (Percutaneous and Other Intracardiac Procedures with and without MCC, respectively).
MDC 5: Cardiac Contractility Device: CMS is adding the following 24 ICD-10-PCS code combinations to MS-DRGs 222, 223, 224, 225, 226 and 227. CMS will delete the 12 clinically invalid code combinations from the GROUPER logic of MS-DRGs 222, 223, 224, 225, 226 and 227 that describe the insertion of contractility modulation device and the insertion of a cardiac lead into the left ventricle. Previously, the MS-DRG GROUPER logic required the combination of the CCM device codes and a left ventricular lead to map to MS-DRGs 222, 223, 224, 225, 226 and 227. The requestor stated the CCM device is contraindicated in patients with a left ventricular lead. But some patients can’t take the left ventricle lead however the cases should still group to DRS 222-227. That is what they are correcting here. Many of these will be outpatient but some are inpatient which is why the DRG logic was corrected. It is corrected so that it can be the device PLUS right ventricular AND / OR left ventricular lead to the drgs 222-227.
MDC 8: Hip and Knee Joint Replacements with Oxidized Zirconium: CMS is creating new MS-DRG 521 (RW 3.0652) (Hip Replacement with Principal Diagnosis of Hip Fracture with MCC) and new MS-DRG 522 (RW 2.1943) (Hip Replacement with Principal Diagnosis of Hip Fracture without MCC). The basis of this request was to better reimburse hospitals for using Oxidized zirconium bearing surfaces since the long-term outcomes are better for these patients. The new DRG without MCC has a higher relative weight than old DRG 470. Previously these cases grouped to MS-DRGs 469 (RW 3.0989), 470 (RW 1.9104) Major hip/knee joint replace or reattach lower extremity, with or without MCC. Refer to Table 6P.1d for a list of procedure codes and Table 6P.1e for a list of diagnosis codes.
MDC 11: Kidney and Urinary Tract/Kidney Transplants: New this year in Pre-MDC MS-DRG and new split DRGs:
- Pre-MDC MS-DRG 019 SIMULTANEOUS PANCREAS AND KIDNEY TRANSPLANT WITH HEMODIALYSIS 6.6601
- MS-DRG 650 KIDNEY TRANSPLANT WITH HEMODIALYSIS WITH MCC 4.5091
- MS-DRG 651 KIDNEY TRANSPLANT WITH HEMODIALYSIS WITHOUT MCC 3.7018
- MS-DRG 652 KIDNEY TRANSPLANT 3.1911
Designating procedure codes 5A1D70Z, 5A1D80Z, and 5A1D90Z that describe hemodialysis as non-O.R. procedures affecting the MS-DRG.
Also, CMS is reassigning ICD-10-CM diagnosis codes T82.41XA, T82.42XA, T82.43XA, and T82.49XA from MDC 05 in MS-DRGs 314, 315, and 316 (Other Circulatory System Diagnoses with MCC, with CC, and without CC/MCC, respectively) to MDC 11 (Diseases and Disorders of the Kidney and Urinary Tract) assigned to MS-DRGs 673, 674, and 675 (Other Kidney and Urinary Tract Procedures with MCC, with CC, and without CC/MCC, respectively) and 698, 699, and 700 (Other Kidney and Urinary Tract Diagnoses with MCC, with CC, and without CC/MCC, respectively).
Also CMS is adding ICD-10-CM codes E09.22, E10.22, E11.22, and E13.22, when reported with a secondary diagnosis of N18.5 or N18.6, to the list of principal diagnosis codes in the subset of GROUPER logic in MS-DRGs 673, 674, and 675 that recognizes the insertion of totally implantable vascular access devices or tunneled vascular access devices as an inpatient procedure for the purposes of hemodialysis.
CMS is also adding ICD-10-CM codes T86.11, T86.12, T86.13, and T86.19 (Kidney transplant complications) to the list of principal diagnosis codes in this subset of GROUPER logic in MS-DRGs 673, 674, and 675.
CMS will remove ICD-10-CM codes I12.9, I13.10, N18.1, N18.2, N18.3, N18.4, and N18.9 from the subset of GROUPER logic in MS-DRGs 673, 674, and 675 that recognizes the insertion of totally implantable vascular access devices or tunneled vascular access devices as an inpatient procedure for the purposes of hemodialysis. (Conditions not typically addressed by the devices)
MDC 17: Myeloproliferative Disease – IVC Filter: Given the similarity in factors such as complexity, resource utilization, and lack of a requirement for anesthesia administration between all procedures describing insertion of a device into the inferior vena cava, it would be more appropriate to designate 06H03DZ, Insertion of Intraluminal Device into Inferior Vena Cava, Percutaneous Approach as Non-O.R. procedure. Therefore, we are removing ICD-10-PCS procedure code 06H03DZ, as an O.R. procedure. Under this change, these procedures would no longer impact MS-DRG assignment. 06H00DZ and 06H04DZ will remain OR procedures.
OR to Non-OR and Vice Versa DRG Changes
Many changes were made that involved cases that grouped to DRGs 981, 982 and 983. The cases were changed out of those DRGs to DRGs within the proper MDC. Also several procedures were either changed to OR procedure or removed as OR procedures. The lengthy list is:
- K61.31, Horseshoe Abscess with Drainage 0J9B0ZZ (Drainage of perineum subcutaneous tissue and fascia, open approach) from MS-DRGs 987, 988, and 989 (Non-Extensive O.R. Procedure Unrelated to Principal Diagnosis with MCC, with CC, and without CC/MCC, respectively) to MS-DRGs 356, 357, and 358 (Other Digestive System O.R. Procedures with MCC, with CC, and without CC/MCC, respectively) in MDC 06.
- Reassign cases reporting a principal diagnosis of M95.4, Acquired deformity of chest and rib or other diagnosis in MDC 08 with a procedure code of
- 0WU807Z Supplement chest wall with autologous tissue substitute, open approach),
- 0WU80KZ Supplement chest wall with nonautologous tissue substitute, open approach
involving the placement of a biological or synthetic material that supports or strengthens the body part from MS-DRGs 981, 982, and 983 (Extensive O.R. Procedure Unrelated to Principal Diagnosis with MCC, with CC, and without CC/MCC, respectively) to MS-DRGs 515, 516, and 517 (Other Musculoskeletal System and Connective Tissue O.R. Procedures, with MCC, with CC, and without CC/MCC, respectively) in MDC 08
- Reassign cases for hepatic malignancy when reported with procedures involving the embolization of a hepatic artery
- 04V33DZ (Restriction of hepatic artery with intraluminal device, percutaneous approach)
- 04L33DZ (Occlusion of hepatic artery with intraluminal device, percutaneous approach)
from MS-DRGs 987, 988, and 989 (Non-Extensive O.R. Procedure Unrelated to Principal Diagnosis with MCC, with CC, and without CC/MCC, respectively) to MS-DRGs 423, 424, and 425 (Other Hepatobiliary or Pancreas Procedures with MCC, with CC, and without CC/MCC, respectively) in MDC 08.
- Reassign cases for R04.2, Hemoptysis when reported with a procedure
- 03LY0DZ (Occlusion of upper artery with intraluminal device, open approach)
- 03LY3DZ (Occlusion of upper artery with intraluminal device, percutaneous approach)
- 03LY4DZ (Occlusion of upper artery with intraluminal device, percutaneous endoscopic approach)
from MS-DRGs 981, 982, and 983 (Extensive O.R. Procedure Unrelated to Principal
Diagnosis with MCC, with CC, and without CC/MCC, respectively) to MS-DRGs 166, 167, and 168 (Other Respiratory Procedures with MCC, with CC, and without CC/MCC, respectively) in MDC 04.
- Reassign cases for R04.0, Epistaxis, hemorrhage of the nose when reported with a procedure
- 03LM3DZ (Occlusion of right external carotid artery with intraluminal device, percutaneous approach),
- 03LN3DZ (Occlusion of left external carotid artery with intraluminal device, percutaneous approach), or
- 03LR3DZ (Occlusion of face artery with intraluminal device, percutaneous approach)
describing percutaneous arterial embolization from MS-DRGs 981, 982, and 983
(Extensive O.R. Procedure Unrelated to Principal Diagnosis with MCC, with CC, and without CC/MCC respectively) NEW MS-DRGs 143, 144, and 145 (Other Ear, Nose, Mouth and Throat O.R. Procedures with MCC, with CC, and without CC/MCC, respectively). CMS deleting MS-DRGs 133 and 134 (Other Ear, Nose, Mouth and Throat O.R. Procedures with CC/MCC and without CC/MCC, respectively).
- CMS is adding ICD-10-PCS procedure codes 0WWG0JZ, 0WWG4JZ, and 0WPG0JZ for revision of synthetic substitute peritoneal cavity to MDC 01 (Diseases and Disorders of the Nervous System) in MS-DRGs 031, 032, and 033 so that these procedures will group correctly.
- Moving diagnoses with the nine procedure codes describing insertion of TIVADs (0JH-0WZ) from MS-DRGS 981-983 to the DRGs describing “Other” procedures for each of the MDCs the diagnoses fall into.
- CMS finalized proposal to add the 161 ICD-10-PCS codes shown in Table 6P.1f associated with multiple trauma and internal fixation of joints to MS-DRGs 957, 958, and 959, Other OR procedures for multiple significant trauma in MDC 24. Previously these grouped to MS–DRGs 981, 982, and 983 (Extensive O.R. Procedure Unrelated to Principal Diagnosis with MCC, with CC, and without CC/MCC, respectively)
- Reassign three procedure codes below from MS-DRGs 981, 982, and 983 (Extensive O.R. Procedure Unrelated to Principal Diagnosis with MCC, with CC, without CC/MCC, respectively) to MS-DRGs 987, 988, and 989 (Non-Extensive Procedure Unrelated to Principal Diagnosis with MCC, with CC, without CC/MCC, respectively).
- 0W3G0ZZ (Control bleeding in peritoneal cavity, open approach) (Designate as an O.R. procedure)
- 0W3G3ZZ (Control bleeding in peritoneal cavity, percutaneous approach)
- 0W3G4ZZ (Control bleeding in peritoneal cavity, endoscopic approach)
- Removing ICD-10-PCS code 0WBC0ZX (Excision of mediastinum, open approach, diagnostic) from MS-DRGs 981 through 983 when reported with a principal diagnosis that is not assigned to one of the MDCs to which the procedure code is assigned to MS-DRGs 987 through 989.
- CMS is changing the designation of ICD-10-PCS codes 0DB90ZZ, 0DBA0ZZ and 0DBB0ZZ (excision of jejunum, ileum or duodenum) from non-extensive O.R. procedures to extensive O.R. procedures for FY 2021. Cases reporting procedure codes 0DB90ZZ, 0DBA0ZZ and 0DBB0ZZ, which are unrelated to the MDC to which the case would otherwise be assigned based on the principal diagnosis, will group to MS-DRGs 981, 982 and 983.
- Removal of below as OR procedures: 3 Revision of feeding device codes, 0DW08UZ, (upper intestinal tract) 0DW68UZ, (stomach) 0DWD8UZ (lower intestinal tract)
- Add 0WBC4ZX, Excision of mediastinum, percutaneous endoscopic approach, diagnostic and 0WBC3ZX, Excision of mediastinum, percutaneous approach, diagnostic as OR procedures and assign them to MS-DRGs 166, 167 and 168, MS–DRGs 628, 629, and 630, MS-DRGs 820, 821, and 822, MS-DRGs 826, 827, and 828 or MS–DRGs 987, 988, and 989 depending on the diagnosis.
- Also after analysis of the excision mediastinum diagnostic, CMS is reassigning procedure codes 0WBC0ZZ, 0WBC3ZZ, and 0WBC4ZZ from MS-DRGs 163, 164, and 165 (Major Chest Procedures with MCC, with CC, and without CC/MCC, respectively) to MS-DRGs 166, 167 and 168 (Other Respiratory System O.R. Procedures with MCC, with CC, and without CC/MCC, respectively).
- 3E0L4GC, Percutaneous Endoscopic Chemical Pleurodesis with talc into pleural cavity as an O.R. procedure assigned to MS-DRGs 166, 167, and 168 (Other Respiratory System O.R. procedures with MCC, CC, without CC/MCC, respectively) and MS-DRG 264 (Other Circulatory System O.R. Procedures) in MDC 05 (Diseases and Disorders of the Circulatory System).
- Adding 0DB64ZZ (Excision of stomach, percutaneous endoscopic approach) 0DB64ZX (Excision of stomach, percutaneous endoscopic approach, diagnostic) as an O.R. procedure assigned to MS-DRGs 326, 327, and 328; (Stomach); 619, 620, and 621 (Endocrine); 820, 821, 822 (Lymphoma); 826 thru 830 (Myeloproliferative). Removed 0DB64Z3 (Excision of stomach, percutaneous endoscopic approach, vertical (sleeve) from DRGs 264, 907-909, 957-959 and adding to above.
- Changing designation of 0F944ZX, Control Bleeding in Peritoneal Cavity, Open Approach from Non-OR procedure to OR procedure, assigned to MS-DRGs 420, 421 and 422 (Hepatobiliary Diagnostic Procedures, with MCC, with CC, and without CC/MCC, respectively)
- Adding as OR procedure “percutaneous endoscopic drainage” codes 0D9W4ZZ and 0D9W04Z to MS-DRGs 356-358, 907-909;
- Adding as OR Procedures 0W9G4ZZ and 0W9G40Z, drainage of peritoneal cavity to MS-DRGs 356-358, 420-422, 673-675 749-750, 802-804, 820-822, 826-828, 907-908.
- Adding as OR Procedures 0F944ZZ, 0F9440Z, drainage of gallbladder to MS-DRGS 408-410; 0F944ZX to 420-422.
- Changed 9 drainage of peritoneum, peritoneal cavity or gallbladder codes from “extensive” OR procedure to “non-extensive” OR procedures.
- Adding as OR Procedure 0W3G0ZZ, (Control bleeding in peritoneal cavity, open approach) that will be assigned to MS-DRGs 264, 356-358, 423-425, 673-675, 820-822, 826-830, 907-909, 957-959 or 981-983 as applicable per principal diagnosis.
- Adding as OR Procedure 0VJS0ZZ, (Inspection of penis, open approach) to MS-DRGs 709 (Penis Procedures with CC/MCC) and 710 (Penis Procedures without CC/MCC) in MDC 12 (Diseases and Disorders of the Male Reproductive System).
Several of the surgical hierarchies were changed to accommodate the changes to the kidney transplant DRGS and new MS-DRGs as added above.
Several changes were made to the Medicare Code Editor (MCE). For example, codes for age-related osteoporosis with current pathological fracture (M80.0—) were added to those that are Adult Only diagnoses. Adding the five new obstetric diagnoses to female only edit AND age conflict edit, patient must be 9 to 64 years of age. Several codes were added to the unacceptable PDX edit to include new manifestation codes.
MCC/CC Severity Levels
Perhaps the biggest surprise was CMS’s decision to NOT change any diagnoses on the MCC list or CC list. Only the expanded (new) codes for FY2021 were added. Coders can review tables 6I.1, 6I.2, 6J.1 and 6J.2 for these additions and deletions.
So there you have it for a summary of the IPPS FY2021 changes. Stay tuned….. In the final Part 4 of this series, the New Technology Add-On Payments (NTAP) will be reviewed in detail.
The information contained in this post is valid at the time of posting. Viewers are encouraged to research subsequent official guidance in the areas associated with the topic as they can change rapidly.
This is Part 5 of a five part series on the new 2021 CPT codes. For the remaining areas we will just briefly summarize the section. Due to the intricate nature of these sections in CPT, it is recommended that the coder read the entire section notes associated with the new codes.
This is Part 4 of a five part series on the new 2021 CPT codes. In this series we will explore the CPT changes in the urinary, nervous, ocular and auditory systems. There are 2 new urinary/male reproductive system codes with no revisions or deletions; 3 new female reproductive codes with 2 deletions, 0 new with 4 deleted nervous system codes with 5 revisions; 5 new eye category III codes; and finally a 2 new auditory codes with one deletion.
This is Part 3 of a five part series on the new 2021 CPT codes. In this series we will explore the cardiovascular system CPT changes. There are 5 new cardiovascular CPT codes added with 0 deletions and 4 revisions.
This is Part 2 of a five part series on the new 2021 CPT codes. In this series we will explore the CPT changes for FY2021 and include some examples to help the coder understand the new codes. There are 0 new musculoskeletal CPT codes added with 0 deletions and 2 major revisions along with an extensive update to arthroscopic loose body removal requirements. For the respiratory system, there were 2 new codes, one code deletion and no revisions.
This is Part 1 of a five part series on the new 2021 CPT codes. In this series we will explore the CPT changes for FY2021 and include examples to help the coder understand the new codes. For 2021 in general, there were 199 new CPT codes added, 54 deleted and 69 revised.
In January, new CPT codes were released. There were 248 new CPT codes added, 71 deleted and 75 revised. Most of the surgery section changes were in the musculoskeletal and cardiovascular subsections. These included procedures such as skin grafting, breast biopsies, deep drug delivery systems, tricuspid valve repairs, aortic grafts and repair of iliac artery.
We have seen many updates and changes to COVID-19 (SARS-CoV-2) since the pandemic started. On January 1, 2021 we will see even more changes as outlined in this post. Also the CMS MS-DRG grouper will be updated to version 38.1 to accommodate the changes.
In the previous three parts of this four-part series, we discussed the new ICD-10-CM diagnosis code changes, ICD-10-PCS procedure code changes and FY2021 IPPS changes. In this last Part 4 of the series, we will review the NTAP procedure codes and reimbursement add-on payments for FY2021.
This is Part 2 of a 4 part series on the FY2021 ICD-10 Code and IPPS changes. In this part, the ICD-10-PCS procedure codes are presented. For FY2021 ICD-10-PCS there are 78,115 total codes (FY2020 total was 77,571); 556 new codes (734 new last year in FY2020)…
This is Part 1 of a 4 part series on the FY2021 changes to ICD-10 and the IPPS. In this part, we discuss some of the new ICD-10-CM diagnosis changes. Here is the breakdown: 72,616 total ICD-10-CM codes for FY2021; 490 new codes (2020 had 273 new codes); 58 deleted codes (2020 had 21 deleted codes); 47 revised codes (2020 had 30 revised codes)
Acute pulmonary edema is the rapid accumulation of fluid within the tissue and space around the air sacs of the lung (lung interstitium). When this fluid collects in the air sacs in the lungs it is difficult to breathe. Acute pulmonary edema occurs suddenly and is life threatening.
“Client S” is a small, not-for-profit, 40 bed micro-hospital in the Southeast. HIA performed a 65-record review this year for Client S and found an opportunity with 15 of them. 9 had an increased reimbursement with a total of $43,228 found.
The coma scale codes (R40.2-) can be used in conjunction with traumatic brain injury codes, acute cerebrovascular disease or sequelae of cerebrovascular disease codes. These codes are primarily for use by trauma registries, but they may be used in any setting where this information is collected. The coma scale may also be used to assess the status of the central nervous system for other non-trauma conditions, such as monitoring patients in the intensive care unit regardless of medical condition.
In the past, there had been an Excludes1 note at I46.- Cardiac arrest that excluded R57.0, Cardiac shock. HIA had also received a letter from AHA on a case in the past that had stated that only I46.- Cardiac arrest would be coded if both were documented. In addition, the Third Quarter Coding Clinic page 26 had a similar case that asked if both could be coded, and AHA had instructed that only I46.9, cardiac arrest, cause unspecified would be coded if both were documented and that the CDC would be looking at possible revision to the Excludes1 note.
A higher CMI corresponds to increased consumption of resources and increased cost of patient care, resulting in increased reimbursement to the facility from government and private payers, like CMS. We know that documentation directly impacts coding.
Lately we have seen several cases where the endarterectomy was assigned along with the coronary artery bypass (CABG) procedure when being performed on the same vessel to facilitate the CABG. A coronary artery endarterectomy is not always performed during a CABG procedure, so when it is performed it becomes confusing as to whether to code it separately or not.
Assign code Z20.828, “Contact with and (suspected) exposure to other viral communicable diseases” for all patients who are tested for COVID-19 and the results are negative, regardless of symptoms, no symptoms, exposure or not as we are in a pandemic.
The Centers for Medicare & Medicaid Services (CMS) announced new procedure codes for treatments of COVID-19 – effective as of August 1, 2020. Among the new codes are Section X New Technology codes for the introduction or infusion of therapeutics including Remdesivir, Sarilumab, Tocilizumab, transfusion of convalescent plasma, as well as introduction of any other or new therapeutic substances for the treatment of COVID-19.
One common element in many value-based programs is risk adjustment using Hierarchical Condition Categories (HCCs) to create a Risk Adjustment Factor (RAF) score. This method ranks diagnoses into categories that represent conditions with similar cost patterns.
Why are so many AKI records being denied? It’s hard to give one answer for why so many AKI records are being denied lately, but most appear to be due to the multiple sets of criteria available for use in determining if a patient has AKI, as well as physician documentation. As stated in Part 3 of this series, there are three main criteria/classifications used to diagnose AKI.
In previous parts of this series we looked at the definitions of AKI/ARF, causes, coding and sequencing, and the common clinical indicators that patients present with that are diagnosed with this condition. In Part 4, we will look at the documentation that should be present to report the diagnosis without fear of denial, as well as when a query is needed to clarify the diagnosis.
If the facility does a COVID-19 test, and test is negative, do I need a diagnosis code. The answer is yes, you will report a Z-code. The Z-code depends on the record documentation and circumstances of testing. For any patient receiving a COVID-19 test, if negative, there MUST e a Z-code to describe why the test was taken. (Test negative for COVID-19 and MD does not override negative results).
In the first parts of this series we looked at definitions of AKI/ARF, causes, coding and sequencing. In Part 3, we will look at what clinical indicators would possibly be present to support the diagnosis of AKI/ARF.
As discussed in Part 1 of this series, AKI/ARF is a common diagnosis that coders see daily. In Part 2, we are going to focus on the different types/specificity of AKI/ARF. We’ll learn what they mean, as well as how to code the diagnosis.
This is part 1 in a series focused on coding of acute kidney injury (AKI) and/or acute renal failure (ARF). AKI/ARF is reported often, but is also one of the most common diagnosis found in denials.
With the proliferation of COVID-19 cases, we thought we would put together a quick reference listing of some of the common scenarios that coders have asked about. As with all coding, coders should follow Official Guidelines for Coding and Reporting and the COVD-19 Frequently Asked Questions document by the AHA.
Effective March 1, Medicare will pay physicians for telehealth services at the same rate as in-person visits for all diagnoses, not just services related to COVID-19. This great for providers whose patients are reluctant to visit the office.
The biggest reasons why some hospital systems are moving to single path coding is to eliminate duplicative processes and to optimize productivity. In addition, costs are reduced when only one coder “touches” the record and completes both types of coding.
Effective with 4/1/2020 discharges, ICD-10-CM code U07.0 is used to report vaping -related disorders. ICD-10-CM code U07.0 (vaping related disorder) should be used when documentation supports that the patient has a lung-related disorder from vaping. This code is found in the new ICD-10-CM Chapter 22. U07.0 will be in listed in the ICD-10-CM manual under a new section: Provisional assignment of new disease of uncertain etiology or emergency use.